Back to
ALPS Advisors Inc.
SMMT
Showing 0 of 5 quarters
Position history for
ALPS Advisors Inc.'s holdings in Summit Therapeutics Inc.
No. ALPS Advisors exited its SMMT (Summit Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 494,924 shares worth $2M. ALPS Advisors first reported SMMT in Q2 2023 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.